Novavax to Cut 40 Sales Positions

In a press release, the biopharmaceutical company said the reductions will allow the company to prepare for a planned partnership of Estrasorb, its topical emulsion for estrogen therapy. The reductions will also more efficiently align the number of sales representatives required to support the existing base of Estrasorb prescribing physicians while allowing the company to continue to cover the highest prescribing obstetricians and gynecologists to grow sales of its women's health products.
iWon